| MSCVX | MSODX | MSCVX / MSODX | |
| Total Expense Ratio | 0.78 | 0.48 | 163% |
| Annual Report Gross Expense Ratio | 0.79 | 0.48 | 165% |
| Fund Existence | 13 years | 7 years | - |
| Gain YTD | 1.572 | 1.803 | 87% |
| Front Load | 3% | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.32B | 1.32B | 100% |
| Annual Yield % from dividends | 3.28 | 3.57 | 92% |
| Returns for 1 year | 6.58 | 7.00 | 94% |
| Returns for 3 years | 11.51 | 12.62 | 91% |
| Returns for 5 years | 1.44 | 3.06 | 47% |
| Returns for 10 years | 18.53 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IGM | 159.36 | 1.09 | +0.69% |
| iShares Expanded Tech Sector ETF | |||
| DFSE | 49.37 | 0.25 | +0.51% |
| Dimensional Emerging Mrkts Sstby Cr 1ETF | |||
| IBRN | 34.83 | 0.14 | +0.40% |
| iShares Neuroscience and Healthcare ETF | |||
| SFEB | 25.83 | 0.09 | +0.35% |
| FT Vest U.S. Small Cap Mod Buf ETF-Feb | |||
| KTUP | 8.92 | -0.29 | -3.15% |
| T-REX 2X Long KTOS Daily Target ETF | |||